Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: A retrospective analysis of 556 patients from India

Radiotherapy and Oncology

Volumn 79, Issue 2, 2006, Pages 142-146

  Saibishkumar, Elantholi P ^a   Patel, Firuza D ^a   Sharma, Suresh C ^a   Karunanidhi, Gunaseelan ^a   Ghoshal, Sushmita ^a   Kumar, Vinay ^a   Kapoor, Rakesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Age; Cancer cervix; External radiation; Gross residual tumor; Overall treatment time

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INDIA; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PELVIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVARIATE ANALYSIS; UTERINE CERVIX CANCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DEVELOPED COUNTRIES; FEMALE; HUMANS; INDIA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 33744986036     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.03.016     Document Type: Article

References (20)

1. Chen S.W., Liang J.A., Yang S.N., Ko H.L., and Lin F.J. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol 67 (2003) 69-76
2. Datta N.R., Pasricha R., Singh U., and Srivastava A. Predictors of survival end points in patients with cancer of the cervix on long-term follow-up: inferences and implications from an audit of patients treated with a specific radiotherapy protocol. Clin Oncol 16 (2004) 536-542
3. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group Trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
4. Fyles A.W., Pintilie M., Kirkbride P., Levin W., Manchul L.A., and Rawlings G.A. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol 35 (1995) 107-117
5. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786
6. Grossman I., Kurohara S.S., Webster J.H., and George F.W. The prognostic significance of tumor response during radiotherapy in cervical carcinoma. Radiology 107 (1973) 411-415
7. Hardt N., Van Nagell J.R., Hanson M., Donaldson E., Yoneda J., and Maruyama Y. Radiation induced tumor regression as a prognostic factor in patients with invasive cervical cancer. Cancer 49 (1982) 35-39
8. Hong J.H., Chen M.S., Lin F.J., and Tang S.G. Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys 22 (1991) 913-917
9. Jacobs A.J., Faris C., Perez C.A., Kao M.S., Galakatos A., and Camel H.M. Short- term persistence of carcinoma of the uterine cervix after radiation-an indicator of long term prognosis. Cancer 57 (1986) 944-950
10. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage 1B cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
11. Lanciano R.M., Won M., Coia L.R., and Hanks G.E. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 20 (1991) 667-676
12. Marcial V.A., and Bosch A. Radiation induced tumor regression in carcinoma of the uterine cervix: prognostic significance. Am J Roentgenol 108 (1970) 113-123
13. Morris M., Eifel P.J., Jiandong L.u., et al. Pelvic radiation and concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N Eng J Med 340 (1999) 1137-1143
14. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54 (1993) 594-606
15. Pearcey R., Brundage M., Drouin P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell carcinoma of the cervix. J Clin Oncol 20 (2002) 966-972
16. Petereit D.G., Sarkaria J.N., and Chappell R. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 32 (1995) 1301-1307
17. Peters W.A., Liu P.Y., Barret R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer cervix. J Clin Oncol 18 (2000) 1606-1613
18. Rose P.G., Brian B.N., Watkin E.B., et al. Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. New Engl J Med 340 (1999) 1144-1153
19. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiotherapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. J Clin Oncol 17 (1999) 1339-1348
20. Wong L.C., Ngan H.Y.S., Cheung A.N.Y., Cheng D.K.L., Ng T.Y., and Choy D.T.K. Chemo radiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol 17 (1999) 2055-2060